News

MedPage Today on MSN9d
ACIP Backs Virus-Like Particle Chikungunya Vaccine for Travelers, Lab Workers
The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and ...
Ophthalmology Times4d
Researchers develop virus-like particle to enhance editing proteins causing inherited eye diseases
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Neuroscience News2d
Experimental Alzheimer’s Vaccine Shows Promise
Researchers have developed a tau-targeting vaccine that could help prevent the progression of Alzheimer’s disease by ...
Bavarian Nordic’s Chikungunya Vaccine Receives Recommendation from U.S. CDC’s Advisory Committee on Immunization Practices (ACIP)
Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions ...
Technology Networks3d
Alzheimer’s Vaccine Shows Promise in Animal Studies
An experimental vaccine that blocks Alzheimer's-related tau protein buildup has generated a robust immune response in both ...
Medical Xpress4d
Clinical trials are the next step for testing vaccine against Alzheimer's-promoting tau protein
The vaccine was developed using a virus-like particle (VLP) platform developed by Bryce Chackerian and David Peabody, Bhaskar's colleagues in Molecular Genetics & Microbiology. VLPs are ...